Send a Tweet
Most Popular Choices
Poll Analyses
Share on Facebook 4 Share on Twitter Printer Friendly Page More Sharing
General News    H3'ed 12/20/15

Big Pharma forces delay of CDC efforts to regulate painkiller prescriptions

Follow Me on Twitter     Message Don Smith
Become a Fan
  (22 fans)

A bold federal effort to curb prescribing of painkillers may be faltering amid stiff resistance from drugmakers, industry-funded groups and, now, even other public health officials.

The Centers for Disease Control and Prevention was on track to finalize new prescribing guidelines for opioid painkillers in January. The guidelines — though not binding — would be the strongest government effort yet to reverse the rise in deadly overdoses tied to drugs such as OxyContin, Vicodin and Percocet.

Drugs
Drugs
(Image by Images_of_Money)
  Details   DMCA
Read the rest of the story HERE:

At www.denverpost.com

 

Must Read 1   Valuable 1  
Rate It | View Ratings

Don Smith Social Media Pages: Facebook page url on login Profile not filled in       Twitter page url on login Profile not filled in       Linkedin page url on login Profile not filled in       Instagram page url on login Profile not filled in

DFA organizer, Democratic Precinct Committee Officer, writer, and programmer. My op-ed pieces have appeared in the Seattle Times, the Seattle Post-Intelligencer, and elsewhere. See http://WALiberals.org and http://TruthSite.org for my writing, my (more...)
 
Go To Commenting
The views expressed herein are the sole responsibility of the author and do not necessarily reflect those of this website or its editors.
Writers Guidelines
Contact AuthorContact Author Contact EditorContact Editor Author PageView Authors' Articles
Support OpEdNews

OpEdNews depends upon can't survive without your help.

If you value this article and the work of OpEdNews, please either Donate or Purchase a premium membership.

STAY IN THE KNOW
If you've enjoyed this, sign up for our daily or weekly newsletter to get lots of great progressive content.
Daily Weekly     OpEdNews Newsletter
Name
Email
   (Opens new browser window)
 

To View Comments or Join the Conversation: